Scipher Medicine

Scipher Medicine is a startup working in the Precision Medicine domain. The platform is intended to employ artificial intelligence to decide which drug will be most effective for each patient. The firm is constructing a molecular map of all protein interactions that identifies genomic signatures and link those to disease and predictive treatment outcomes. Scipher Medicine can predict whether a patient will respond to a targeted medicine using a simple blood sample and RNA analysis before the therapy is prescribed. Having raised a total of $117 million in three financing rounds since its inception in 2015, Scipher Medicine announced the close of a $110M round led by Cowen Inc., with participation from new investors Neuberger Berman, Hitachi Ventures, Laurion Capital Management LP, and Monashee Investment Management LLC. Existing investors Northpond Ventures, aMoon Fund, Khosla Ventures, Optum Ventures, Echo Health Ventures, and Alumni Ventures also participated.